Ruling says licensees do not have to first breach their contracts in order to claim patent infringement.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Related links
Rights and permissions
About this article
Cite this article
Waltz, E. Supreme Court boosts licensees in biotech patent battles. Nat Biotechnol 25, 264–265 (2007). https://doi.org/10.1038/nbt0307-264
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt0307-264
This article is cited by
-
Cabilly patent finale
Nature Biotechnology (2008)
-
News in brief
Nature Biotechnology (2007)
-
Industry waits for fallout from Cabilly
Nature Biotechnology (2007)